Hormone replacement therapy and osteoporosis

Maturitas

Volumn 23, Issue SUPPL., 1996, Pages

  Christiansen, Claus ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Estrogen; Hormone replacement therapy (HRT); Menopause; Osteoporosis; Progestogen

Indexed keywords

GESTONORONE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE;

ADULT; BONE ATROPHY; BONE MASS; CALCIUM METABOLISM; ESTROGEN BLOOD LEVEL; FEMALE; FRACTURE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; OSTEOPOROSIS; PROGESTERONE BLOOD LEVEL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0029766841     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(96)01016-X     Document Type: Article

References (38)

1. Consensus Development Conference: Prophylaxis and treatment of osteoporosis. Am J Med 1991; 90: 107-110.
2. Melton LJ. Epidemiology of fractures. In: Riggs BL, Melton LJ, eds. Osteoporosis: etiology, diagnosis and management. 1988; 133-154.
3. Nilas L, Christiansen C. Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987; 65: 697-702.
4. Thomsen K, Gotfredsen A, Christiansen C. Is postmenopausal bone loss an age-related phenomenon? Calcif Tissue Int 1986; 39: 123-127.
5. Hammond CB, Maxson WS. Current status of estrogen therapy for the menopause. Fertil Steril 1982; 37: 5-25.
6. Mashchak CA, Lobo RA, Dozono-Takono R, Eggena P, Nakomura RM, Brenner PF, Mishell DR. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982; 144: 511-518.
7. Hammond CB, Maxson WS. Estrogen replacement therapy. Clin Obstet Gynecol 1986; 29: 407-430.
8. Neumann F. The physiological action of progesterone and the pharmacological effects of progestogen. A short review. Postgrad Med 1978; 54: 11-24.
9. Nordin BBC. Calcium. J Food Nutr 1986; 42: 67-82.
10. Parfitt AM. Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int 1979; 28: 1-5.
11. Riggs BL, Mann KG. Assessment of bone turnover in osteoporosis using biochemical marker. In: Christiansen et al., eds. Osteoporosis 1987. Proceedings of the International Symposium on Osteoporosis, Aalborg 1987. Osteopress Aps 1987; 2: 672-676.
12. Christiansen C, Rødbro P, Tjellesen L. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. Acta Med Scand 1984; 216: 11-17.
13. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K-E, Transbøl I. Prevention of early postmenopausal bone loss. Controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273-279.
14. Riis BJ, Thomsen K, Strom V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 1987; 156: 61-65.
15. Lindsay R, Hart DM, Purdie D, Ferguson MM, Clark AS, Kraszewski A. Comparative effects of estrogen and a progestogen on bone loss in postmenopausal women. Clin Sci 1978; 54: 193-195.
16. Abdalla HI, Hart DM, Lindsay R, Leggate I, Hooke A. Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol 1985; 66: 789-792.
17. Christiansen C, Christensen MS, Transbøl I. Bone mass in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy. Lancet 1981; i: 459-461.
18. Riis BJ, Jensen J, Christiansen C. Cyproteroneacetate, on alternative gestagen in postmenopausal oestrogen/ gestagen therapy? Clin Endocrinol 1987; 26: 327-334.
19. Riis BJ, Thomsen K, Strom V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on bone loss. Am J Obstet Gynecol 1987; 156: 61-65.
20. Lindsay R, Aitken JM, Andersen JB, Hart DMM, MacDonald EB, Clarke AC. Long-term prevention of postmenopausal Osteoporosis by oestrogen. Lancet 1976; i: 1038-1040.
21. 3 and calcium. Clin Endocrinol 1982; 16: 515-524.
22. Quigley MET, Martin PL, Burnier AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987; 156: 1516-1523.
23. Christiansen C, Riis BJ. 17β-Estradiol and continuous norethisterone: a unique treatment of established osteoporosis in elderly women. J Clin Endocrinol Metab 1990; 71: 836-841.
24. Horsman A, Jones M, Francis R, Nordin BBC. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med 1983; 309: 1405-1407.
25. Christensen MS, Hagen C, Christiansen C, Transbøl I. Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women. Placebo-controlled trial of its gynecologic and metabolic actions. Am J Obstet Gynecol 1982; 144: 873-879.
26. Lindsay R, Hart CM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1983; 63: 759-763.
27. Gotfredsen A, Nilas L, Riis BJ, Thomsen K, Christiansen C. Bone changes occurring spontaneously and caused by oestrogen in early postmenopausal women; a local or generalized phenomenon? Br Med J 1986; 292: 1098-1100.
28. Riis BJ, Christiansen C. Measurement or spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med 1988; 84: 646-653.
29. Ribot C, Tremollierés F, Pouillés JM. Cydic Estraderm TTS 50 plus oral progestogen in the prevention of postmenopausal bone loss over 24 months. In: Christiansen et al., eds. Osteoporosis 1990. Proceeding of the International Symposium of Osteoporosis 1990; 2: 1979-1984.
30. Lindsay R, Hart DM, Maclean A, Clark AC, Kraszewski A, Garnwood J. Bone response to termination of estrogen treatment. Lancet 1978; i: 1321-1327.
31. Weiss NS, Ure CL, Ballard JH, Williams AR, Dalin JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980; 303: 1195-1198.
32. Lufkin EG, Hodgson SF, Kotowicz MA, O'Fallon WM, Wahner HW, Riggs BL. The use of transdermal estrogen treatment in osteoporosis. In: Christiansen C, Overgård K, eds. Osteoporosis 1990. Proceeding of the Third International Symposium on Osteoporosis, Copenhagen, Denmark 14-20 October 1990. Osteopress 1990; 3: 1995-1998.
33. Kiel DP, Felson DT, Andersen JJ, Wilson PWF, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham study. N Engl J Med 1987; 317: 1169-1174.
34. Heaney RP, Recker RR, Saville PD. Menopausal changes in calcium balance performance. J Lab Clin Med 1978; 92: 953-963.
35. Nilas L, Christiansen C, Rødbro P. Calcium supplementation and postmenopausal bone loss. Br Med J 1984; 289: 1103-1106.
36. Riis BJ, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss; a doubleblind controlled clinical study. N Engt J Med 1987; 316: 173-177.
37. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Int Med 1987; 104: 40-44.
38. Riis BJ, Nilas L, Christiansen C. Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss? Bone Miner 1987; 2: 1-5.